Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease

doi:10.3748/wjg.119898

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 35

This Article

(6)

(0)

(50)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Sep 21, 2026; 32(35): 119898
Published online Sep 21, 2026. doi: 10.3748/wjg.119898

Full Size Figure Download Figure

Figure 3 Pathophysiological mechanisms that link metabolic dysfunction-associated steatotic liver disease to cardiovascular disease. MASLD: Metabolic dysfunction-associated steatotic liver disease; RAAS: Renin-angiotensin-aldosterone system; SNS: Sympathetic nervous system; CAC: Coronary artery calcification; CAD: Coronary artery disease; CHD: Coronary heart disease; ACS: Acute coronary syndrome; PAD: Peripheral artery disease; CVD: Cardiovascular disease; AF: Atrial fibrillation; QTc: Heart rate-corrected QT; HFpEF: Heart failure with preserved ejection fraction; LV: Left ventricular; LVH: Left ventricular hypertrophy.

Citation: Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Garcia-Bañuelos J, Petri MH, Armendariz-Borunda J. Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease. World J Gastroenterol 2026; 32(35): 119898
URL: https://www.wjgnet.com/1007-9327/full/v32/i35/119898.htm
DOI: https://dx.doi.org/10.3748/wjg.119898

Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Garcia-Bañuelos J, Petri MH, Armendariz-Borunda J. Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease. World J Gastroenterol 2026; 32(35): 119898 [DOI: 10.3748/wjg.119898]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.